Sweet JM - Search Results

1

Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis.

Beheshti B, Park PC, Sweet JM, Trachtenberg J, Jewett MA, Squire JA. Beheshti B, et al. Among authors: sweet jm. Neoplasia. 2001 Jan-Feb;3(1):62-9. doi: 10.1038/sj.neo.7900125. Neoplasia. 2001. PMID: 11326317 Free PMC article.

2

Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.

Nam RK, Elhaji Y, Krahn MD, Hakimi J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Nam RK, et al. J Urol. 2000 Aug;164(2):567-72. J Urol. 2000. PMID: 10893645

3

V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression.

Nam RK, Toi A, Vesprini D, Ho M, Chu W, Harvie S, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Nam RK, et al. Urology. 2001 Jan;57(1):199-204. doi: 10.1016/s0090-4295(00)00928-6. Urology. 2001. PMID: 11164181

4

Development of a radiofrequency based thermal therapy technique in an in vivo porcine model for the treatment of small renal masses.

Rendon RA, Gertner MR, Sherar MD, Asch MR, Kachura JR, Sweet J, Jewett MA. Rendon RA, et al. J Urol. 2001 Jul;166(1):292-8. J Urol. 2001. PMID: 11435889

5

The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy.

Rendon RA, Kachura JR, Sweet JM, Gertner MR, Sherar MD, Robinette M, Tsihlias J, Trachtenberg J, Sampson H, Jewett MA. Rendon RA, et al. Among authors: sweet jm. J Urol. 2002 Apr;167(4):1587-92. J Urol. 2002. PMID: 11912369

6

Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma.

Vukovic B, Park PC, Al-Maghrabi J, Beheshti B, Sweet J, Evans A, Trachtenberg J, Squire J. Vukovic B, et al. Oncogene. 2003 Apr 3;22(13):1978-87. doi: 10.1038/sj.onc.1206227. Oncogene. 2003. PMID: 12673203

7

Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection.

Nam RK, Zhang WW, Trachtenberg J, Diamandis E, Toi A, Emami M, Ho M, Sweet J, Evans A, Jewett MA, Narod SA. Nam RK, et al. J Clin Oncol. 2003 Jun 15;21(12):2312-9. doi: 10.1200/JCO.2003.11.007. J Clin Oncol. 2003. PMID: 12805332

8

Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy.

Nam RK, Jewett MA, Krahn MD, Robinette MA, Tsihlias J, Toi A, Ho M, Evans A, Sweet J, Trachtenberg J. Nam RK, et al. Can J Urol. 2003 Jun;10(3):1891-8. Can J Urol. 2003. PMID: 12892576

9

A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer.

Trudel S, Trachtenberg J, Toi A, Sweet J, Li ZH, Jewett M, Tshilias J, Zhuang LH, Hitt M, Wan Y, Gauldie J, Graham FL, Dancey J, Stewart AK. Trudel S, et al. Cancer Gene Ther. 2003 Oct;10(10):755-63. doi: 10.1038/sj.cgt.7700626. Cancer Gene Ther. 2003. PMID: 14502228 Clinical Trial.

10

Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.

Nam RK, Zhang WW, Trachtenberg J, Jewett MA, Emami M, Vesprini D, Chu W, Ho M, Sweet J, Evans A, Toi A, Pollak M, Narod SA. Nam RK, et al. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1429-37. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693733 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters